LC/MS/MS Method Package for Short Chain Fatty Acids
For LabSolutions™ LCMS Software
Short-Chain Fatty Acids and Organic Acids Targeted for Analysis
Of the short-chain fatty acids produced by intestinal bacteria, acetic acid, propionic acid, and butyric acid are well known, and it has been reported that there are some connections between them and lifestyle-related diseases such as obesity and diabetes. Generally speaking, short-chain fatty acids are highly volatile and highly hydrophilic. This makes it difficult to perform LCMS analysis using a conventional reverse phase system. For that reason, this method package targets short-chain fatty acids (C2 to C5) that have been derivatized using 3-nitrophenylhydrazine (3-NPH). After setting MRM transitions, it can be used for the simultaneous analysis (of 22 components), including organic acids related to the central metabolic pathways.
MRM Transition Settings
When making MRM transition settings, selectivity can be enhanced by specifying characteristic product ions for 3-nitrophenylhydrazine derivatives. Note that some organic acids have a carbonyl group derived from ketones, so 3-nitrophenylhydrazine derivatives that reacted with carboxylic acid and the carbonyl group are targeted for MRM transition.
Pretreatment Protocol Including Derivatization
The entire protocol necessary for pretreatment, including the derivatization step using 3-nitrophenylhydrazine, is contained in the Instruction Manual for this method package. By following these procedures, an analyst should be able to perform the entire process, from derivatization to data acquisition and data analysis, immediately after the package is introduced.
For the derivatization using 3-nitrophenylhydrazine, carbodiimide is used as a condensing agent, and reaction proceeds under mild conditions. Moreover, in order to efficiently carry out reactions with both short-chain fatty acids and organic acids, this method package includes derivatization using 3-NPH instead of the more commonly used 2-NPH. Also, 3-NPH derivatizations after reactions are stable, and quantitative analysis of the short-chain fatty acids or organic acids in the sample can be performed through reaction with an appropriate amount of derivatization reagent. Additionally, as reactions take place in water solutions using this derivatization reagent, the sample will not be dried and volatile components will not be lost.
The following example shows an analysis using the LCMS-8060 of a standard mixed solution of short-chain fatty acids/organic acids. An MRM chromatogram of short-chain fatty acids/organic acids derivatized using 3-NPH is shown. As can be seen, sufficient separations of the components, such as the structural isomers butyric acid, isobutyric acid, fumaric acid, maleic acid, citric acid, and isocitric acid were obtained. This method package includes MRM transitions that were formulated beforehand in order to achieve optimization for 3-NPH derivatizations for short-chain fatty acids/organic acids. As a result, short-chain fatty acids (C2 to C5) and organic acids representative of central metabolic pathways, which are difficult to analyze with LCMS using a conventional reversed phase system, can be analyzed simultaneously.
Remarks and Precautions
LabSolutions LCMS Ver. 5.99SP2 or later is required.
LabSolutions is a trademark of Shimadzu Corporation.
News / Events
Cosmetics and Personal Care Products
The environment surrounding cosmetics and personal care products is changing. In addition to serving the original aesthetic purpose, cosmetics are required to be environmentally friendly and impart no adverse effects on animals.
Shimadzu has released the LC/MS/MS Method Package for Reactive Sulfur Profiling.
Sample Pretreatment Protocols and Analytical Methods for 17 Sulfur-Containing Metabolites,Including Reactive Sulfur Species
Shimadzu has released the LCMS-9050 Quadrupole Time-of-Flight Liquid Chromatograph Mass Spectrometer.
The LCMS-9050 is a quadrupole Time-of-Flight (Q-TOF) mass spectrometer system designed with technologies developed for Shimadzu LCMS series models and that results in among the highest mass accuracy stability levels available.
Dementia / Alzheimer‘s disease
Shimadzu is a leading driver in developing healthcare solutions with technology developments ranging from advanced imaging systems for use in medical diagnosis and treatment, engineering mass spectrometry-based solutions for exploring ways to discover disease biomarkers as well as building MS solutions for daily routine quantitation in biological fluids.
Anti-doping policies, rules and regulations are governed by the World Anti-Doping Agency (WADA). Doping is not only harmful to athletes who take performance-boosting drugs, but also affects the integrity of a sport. Shimadzu instruments can help ensure clean sports and here are a few applications.
Shimadzu has released the LCMS-2050 High-Performance Liquid Chromatograph Mass Spectrometer.
The LCMS-2050 single quadrupole mass spectrometer combines the user-friendliness of an LC detector with the excellent performance of MS to provide a complete package of easy to use high-level performance and compactness.
2 Zero hunger
6 Clean water and sanitation